Published in Br J Haematol on December 01, 1998
FusionFinder: a software tool to identify expressed gene fusion candidates from RNA-Seq data. PLoS One (2012) 1.11
Characterization of the different BCR-ABL transcripts with a single multiplex RT-PCR. J Mol Diagn (2004) 0.84
A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia. Mol Cytogenet (2016) 0.80
Novel BCR-ABL1 fusion and leukemic mutations of SETBP1, PAX5, and TP53 detected by next generation sequencing in chronic myeloid leukemia. Cancer Biol Ther (2016) 0.76
Roots of clinical resistance to STI-571 cancer therapy. Science (2001) 9.78
Accident analysis of large-scale technological disasters applied to an anaesthetic complication. Can J Anaesth (1992) 4.01
Testicular cancer in England and Wales: some epidemiological aspects. Lancet (1981) 3.00
Onset of obesity in a 36 year birth cohort study. Br Med J (Clin Res Ed) (1986) 2.83
Bacterioplankton: a sink for carbon in a coastal marine plankton community. Science (1986) 2.76
Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing (1994) 2.55
Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women. Br Med J (Clin Res Ed) (1987) 2.54
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. Blood (2001) 2.50
A potent inhibitor of Taq polymerase copurifies with human genomic DNA. Nucleic Acids Res (1988) 2.26
Nonaccidental poisoning in childhood. Arch Dis Child (1979) 2.15
Current models of "quality"--an introduction for anaesthetists. Can J Anaesth (1993) 2.11
Better specimens from the female genital tract. Br Med J (1971) 2.10
Bladder cancer as a prescribed industrial disease: a guide for clinicians. Br Med J (1980) 1.99
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88
A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood (1998) 1.87
Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood (2000) 1.84
A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia (1995) 1.81
Hyperpolarization-activated calcium channels at the tip of Arabidopsis root hairs. Proc Natl Acad Sci U S A (2000) 1.77
Identification of a novel Rab11/25 binding domain present in Eferin and Rip proteins. J Biol Chem (2001) 1.70
Vacuolar H(+)-translocating pyrophosphatases: a new category of ion translocase. Trends Biochem Sci (1992) 1.65
Occupational bladder tumour cases identified during ten years' interviewing of patients. Br J Urol (1976) 1.63
The study of mortality variations in small administrative areas of England and Wales, with special reference to cancer. J Epidemiol Community Health (1980) 1.62
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia (2006) 1.62
Appropriate controls for reverse transcription polymerase chain reaction (RT-PCR) Br J Haematol (1994) 1.60
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia (2012) 1.60
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia (1999) 1.55
Prevalence of bacteriuria in infants and preschool children. Lancet (1974) 1.53
Anaesthetic simulation and lessons to be learned from aviation. Can J Anaesth (1997) 1.52
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol (1997) 1.48
Social and regional differences in food and alcohol consumption and their measurement in a national birth cohort. J Epidemiol Community Health (1988) 1.47
The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood (2001) 1.47
The cost of an established quality assurance programme: is it worth it? Can J Anaesth (1994) 1.46
Polymerase chain reaction automated at low cost. Nucleic Acids Res (1988) 1.46
Chronic physical illness in childhood: psychological and social effects in adolescence and adult life. Dev Med Child Neurol (1989) 1.45
Every-other-week methotrexate in patients with rheumatoid arthritis. A double-blind, placebo-controlled prospective study. Arthritis Rheum (1995) 1.44
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood (1995) 1.43
Intensive treatment of renal failure in patients with myeloma. Clin Lab Haematol (1994) 1.43
Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha. Br J Haematol (1995) 1.43
Structural aspects of anaesthetic care. Can J Anaesth (1994) 1.43
Stomach cancer mortality in Worksop and other Nottinghamshire mining towns. Br J Cancer (1980) 1.41
Hepatic necrosis after cardiac surgery. Anaesth Intensive Care (1995) 1.40
Mitozantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia. Br J Haematol (1991) 1.40
Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet (1992) 1.40
A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia. Br J Haematol (1994) 1.39
Strongyloidiasis, angio-oedema and natural killer cell lymphocytosis. Br J Dermatol (1999) 1.37
Guidelines and techniques for the investigation of anesthetic accidents. J Clin Anesth (1993) 1.37
Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci U S A (1997) 1.36
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36
Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J Clin Oncol (2000) 1.33
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1998) 1.30
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia (2009) 1.29
Bladder cancer as a prescribed industrial disease. Br Med J (1980) 1.28
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Blood (2000) 1.27
Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood (1998) 1.25
Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood (1995) 1.25
Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol (2004) 1.25
Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet (1993) 1.24
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant (2005) 1.23
Doing what is right in anesthesia. CMAJ (1986) 1.22
Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer (1993) 1.21
Anesthesia in 1984: how safe is it? Can Med Assoc J (1984) 1.20
Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol (1999) 1.19
Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia. Blood (1999) 1.18
Long term mortality study of chromate pigment workers who suffered lead poisoning. Br J Ind Med (1984) 1.18
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. Bone Marrow Transplant (2010) 1.16
p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood (1996) 1.15
Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Q J Med (1991) 1.15
The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood (1993) 1.14
Thigmotropism and stretch-activated channels in the pathogenic fungus Candida albicans. Microbiology (1998) 1.14
The detection of gas bubbles in guinea-pigs after decompression from air saturation dives using ultrasonic imaging. J Physiol (1980) 1.13
Lung cancer mortality among workers making lead chromate and zinc chromate pigments at three English factories. Br J Ind Med (1984) 1.12
Neutrophil chemotaxis and adhesion in preterm babies. Arch Dis Child (1992) 1.11
Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12). Blood (1999) 1.11
Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia. Br J Haematol (2001) 1.10
Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res (1999) 1.10
Adverse events in anaesthesia: the wrong drug. Can J Anaesth (1994) 1.09
Relation between periventricular haemorrhage and ischaemic brain lesions diagnosed by ultrasound in very pre-term infants. Lancet (1985) 1.08
Pregnancy associated aplastic anaemia: a report of five cases and review of current management. Br J Haematol (1989) 1.08
Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse. Br J Haematol (2001) 1.08
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant (2008) 1.08
Investigating glutamate receptor-like gene co-expression in Arabidopsis thaliana. Plant Cell Environ (2008) 1.08
Type 5 acid phosphatase. Sequence, expression and chromosomal localization of a differentiation-associated protein of the human macrophage. Eur J Biochem (1990) 1.07
Retroviral transduction of Philadelphia-positive chronic myeloid leukemia cells with a human mutant p53 cDNA and its effect on in vitro proliferation. Exp Hematol (1994) 1.07
ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5. Neoplasia (1999) 1.06
Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haematol (2003) 1.05
Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood (1996) 1.04
The relaxant and spasmogenic effects of some xanthine derivatives acting on guinea-pig isolated trachealis muscle. Br J Pharmacol (1988) 1.03
Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood (1996) 1.03
Trial by media: the bupivacaine story. Can Anaesth Soc J (1984) 1.02
Detection and quantification of residual disease in chronic myelogenous leukemia. Leukemia (2000) 1.02
Calcium uptake by plant cells--channels and pumps acting in concert. Trends Plant Sci (2001) 1.02
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A. Bone Marrow Transplant (1992) 1.01
Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia. Leukemia (2009) 1.01